Literature DB >> 15245507

Clinical, haematological and histomorphological profile of adult myelodysplastic syndrome. Study of 96 cases in a single institute.

T Chatterjee1, A Dixit, M Mohapatra, S Tyagi, P K Gupta, P Mishra, M Bhattacharya, A S Karan, H P Pati, R Saxena, V P Choudhry.   

Abstract

Myelodysplastic syndromes (MDS) are clonal haematopoietic stem cell disorders characterised by ineffective and dyspoietic haematopoiesis. The natural history of these disorders is variable and ranges from a chronic to a rapid course towards leukaemic progression. Certain shortcomings have been encountered in the French-American-British (FAB) classification over the years, and therefore there is a need for an alternative method of classification. In 1999, the WHO published a revised classification of MDS. In the present study, we have analysed the clinical, haematological and histomorphological features in 96 cases of primary MDS seen in the department of haematology at the All India Institute of Medical Sciences (AIIMS) over a 6-yr period (1996-2001). Both FAB and WHO classifications have been incorporated and the Bournemouth scoring system applied in each case at presentation. The Bournemouth scoring system, in the absence of a cytogenetic study, offers a good prognostication and long-term survival estimate.

Entities:  

Mesh:

Year:  2004        PMID: 15245507     DOI: 10.1111/j.1600-0609.2004.00271.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

1.  A Prospective, Cross Sectional Study of PNH Clone in MDS Patients Using High Sensitivity Flowcytometry: A Single Center Experience.

Authors:  Faran Naim; Amrita Saraf; Jasmita Dass; Vandana Arya; Sabina Langer; Nitin Gupta; Ajay Sharma; Jyoti Kotwal
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-24       Impact factor: 0.900

2.  Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients.

Authors:  Mostafa Paridar; Kazem Zibara; Seyed Esmaeil Ahmadi; Abbas Khosravi; Maral Soleymani; Ebrahim Azizi; Omid Kiani Ghalesardi
Journal:  Mol Cytogenet       Date:  2021-05-08       Impact factor: 2.009

3.  Immune dysregulation in myelodysplastic syndrome.

Authors:  Chiharu Sugimori; Alan F List; Pearlie K Epling-Burnette
Journal:  Hematol Rep       Date:  2010-01-26

4.  Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center.

Authors:  Santhosh Narayanan
Journal:  J Blood Med       Date:  2017-02-23

5.  Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification.

Authors:  Rafia Mahmood; Chaudry Altaf; Parvez Ahmed; Saleem Ahmed Khan; Hamid Saeed Malik
Journal:  Turk J Haematol       Date:  2017-06-07       Impact factor: 1.831

6.  A mechanism for 1,4-Benzoquinone-induced genotoxicity.

Authors:  Mi Young Son; Chu-Xia Deng; Jan H Hoeijmarkers; Vivienne I Rebel; Paul Hasty
Journal:  Oncotarget       Date:  2016-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.